747 related articles for article (PubMed ID: 17128270)
1. v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation.
Lee SH; Rho J; Jeong D; Sul JY; Kim T; Kim N; Kang JS; Miyamoto T; Suda T; Lee SK; Pignolo RJ; Koczon-Jaremko B; Lorenzo J; Choi Y
Nat Med; 2006 Dec; 12(12):1403-9. PubMed ID: 17128270
[TBL] [Abstract][Full Text] [Related]
2. Cell fusion in osteoclasts plays a critical role in controlling bone mass and osteoblastic activity.
Iwasaki R; Ninomiya K; Miyamoto K; Suzuki T; Sato Y; Kawana H; Nakagawa T; Suda T; Miyamoto T
Biochem Biophys Res Commun; 2008 Dec; 377(3):899-904. PubMed ID: 18952053
[TBL] [Abstract][Full Text] [Related]
3. Role of CSF-1 in bone and bone marrow development.
Cecchini MG; Hofstetter W; Halasy J; Wetterwald A; Felix R
Mol Reprod Dev; 1997 Jan; 46(1):75-83; discussion 83-4. PubMed ID: 8981367
[TBL] [Abstract][Full Text] [Related]
4. Vacuolar-type H+-ATPase-mediated acidosis promotes in vitro osteoclastogenesis via modulation of cell migration.
Kim JM; Min SK; Kim H; Kang HK; Jung SY; Lee SH; Choi Y; Roh S; Jeong D; Min BM
Int J Mol Med; 2007 Mar; 19(3):393-400. PubMed ID: 17273786
[TBL] [Abstract][Full Text] [Related]
5. DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells.
Yagi M; Miyamoto T; Sawatani Y; Iwamoto K; Hosogane N; Fujita N; Morita K; Ninomiya K; Suzuki T; Miyamoto K; Oike Y; Takeya M; Toyama Y; Suda T
J Exp Med; 2005 Aug; 202(3):345-51. PubMed ID: 16061724
[TBL] [Abstract][Full Text] [Related]
6. Luteolin inhibition of V-ATPase a3-d2 interaction decreases osteoclast resorptive activity.
Crasto GJ; Kartner N; Yao Y; Li K; Bullock L; Datti A; Manolson MF
J Cell Biochem; 2013 Apr; 114(4):929-41. PubMed ID: 23129004
[TBL] [Abstract][Full Text] [Related]
7. Specific inhibitors of vacuolar H(+)-ATPase trigger apoptotic cell death of osteoclasts.
Okahashi N; Nakamura I; Jimi E; Koide M; Suda T; Nishihara T
J Bone Miner Res; 1997 Jul; 12(7):1116-23. PubMed ID: 9200012
[TBL] [Abstract][Full Text] [Related]
8. Vacuolar H+-ATPase d2 subunit: molecular characterization, developmental regulation, and localization to specialized proton pumps in kidney and bone.
Smith AN; Jouret F; Bord S; Borthwick KJ; Al-Lamki RS; Wagner CA; Ireland DC; Cormier-Daire V; Frattini A; Villa A; Kornak U; Devuyst O; Karet FE
J Am Soc Nephrol; 2005 May; 16(5):1245-56. PubMed ID: 15800125
[TBL] [Abstract][Full Text] [Related]
9. Adrm1 interacts with Atp6v0d2 and regulates osteoclast differentiation.
Kim T; Ha HI; Kim N; Yi O; Lee SH; Choi Y
Biochem Biophys Res Commun; 2009 Dec; 390(3):585-90. PubMed ID: 19818731
[TBL] [Abstract][Full Text] [Related]
10. Proteomic identification of the TRAF6 regulation of vacuolar ATPase for osteoclast function.
Ryu J; Kim H; Lee SK; Chang EJ; Kim HJ; Kim HH
Proteomics; 2005 Nov; 5(16):4152-60. PubMed ID: 16196101
[TBL] [Abstract][Full Text] [Related]
11. Altered hematopoiesis in glypican-3-deficient mice results in decreased osteoclast differentiation and a delay in endochondral ossification.
Viviano BL; Silverstein L; Pflederer C; Paine-Saunders S; Mills K; Saunders S
Dev Biol; 2005 Jun; 282(1):152-62. PubMed ID: 15936336
[TBL] [Abstract][Full Text] [Related]
12. NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP).
Kim K; Lee SH; Ha Kim J; Choi Y; Kim N
Mol Endocrinol; 2008 Jan; 22(1):176-85. PubMed ID: 17885208
[TBL] [Abstract][Full Text] [Related]
13. Myeloid blasts are the mouse bone marrow cells prone to differentiate into osteoclasts.
de Vries TJ; Schoenmaker T; Hooibrink B; Leenen PJ; Everts V
J Leukoc Biol; 2009 Jun; 85(6):919-27. PubMed ID: 19304896
[TBL] [Abstract][Full Text] [Related]
14. Disordered osteoclast formation and function in a CD38 (ADP-ribosyl cyclase)-deficient mouse establishes an essential role for CD38 in bone resorption.
Sun L; Iqbal J; Dolgilevich S; Yuen T; Wu XB; Moonga BS; Adebanjo OA; Bevis PJ; Lund F; Huang CL; Blair HC; Abe E; Zaidi M
FASEB J; 2003 Mar; 17(3):369-75. PubMed ID: 12631576
[TBL] [Abstract][Full Text] [Related]
15. [Bone and bone related biochemical examinations. Bone and collagen related metabolites. Regulatory mechanisms of osteoclast differentiation and function].
Takahashi N
Clin Calcium; 2006 Jun; 16(6):940-47. PubMed ID: 16751689
[TBL] [Abstract][Full Text] [Related]
16. Osteoclast culture and resorption assays.
Bradley EW; Oursler MJ
Methods Mol Biol; 2008; 455():19-35. PubMed ID: 18463808
[TBL] [Abstract][Full Text] [Related]
17. Treg cells suppress osteoclast formation: a new link between the immune system and bone.
Zaiss MM; Axmann R; Zwerina J; Polzer K; Gückel E; Skapenko A; Schulze-Koops H; Horwood N; Cope A; Schett G
Arthritis Rheum; 2007 Dec; 56(12):4104-12. PubMed ID: 18050211
[TBL] [Abstract][Full Text] [Related]
18. Atp6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification.
Li YP; Chen W; Liang Y; Li E; Stashenko P
Nat Genet; 1999 Dec; 23(4):447-51. PubMed ID: 10581033
[TBL] [Abstract][Full Text] [Related]
19. Comparison of morphological effects of PGE2 and TGFbeta on osteoclastogenesis induced by RANKL in mouse bone marrow cell cultures.
Gardner CR
Cell Tissue Res; 2007 Oct; 330(1):111-21. PubMed ID: 17694327
[TBL] [Abstract][Full Text] [Related]
20. Receptor activator of nuclear factor-kappaB ligand-induced mouse osteoclast differentiation is associated with switching between NADPH oxidase homologues.
Sasaki H; Yamamoto H; Tominaga K; Masuda K; Kawai T; Teshima-Kondo S; Matsuno K; Yabe-Nishimura C; Rokutan K
Free Radic Biol Med; 2009 Jul; 47(2):189-99. PubMed ID: 19409483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
